Sanofi's Shock Therapy Enrages the French

Workers protest closures as the CEO abandons existing projects
Sanofi scientists demonstrate against job cuts Photograph by Remy Gabalda/AFP/Getty Images

Among the major French companies that have triggered protests at home this summer by announcing job cuts, Sanofi stands out for its audacity. France’s biggest drugmaker plans to slash its research and development staff in Toulouse and Montpellier and is shifting its focus across the Atlantic to Cambridge, Mass.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.